Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $32.3500 (-3.69%) ($32.1400 - $32.3500) on Wed. Jan. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.71% (three month average) | RSI | 21 | Latest Price | $32.3500(-3.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.8% a day on average for past five trading days. | Weekly Trend | HALO declines -5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(53%) IWO(48%) IWM(47%) IWN(44%) IWC(43%) | Factors Impacting HALO price | HALO will decline at least -1.355% in a week (0% probabilities). VIXM(-27%) UUP(-13%) VXX(-9%) TBT(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.355% (StdDev 2.71%) | Hourly BBV | -2.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $20.74(-35.89%) | Resistance Level | $36.4 | 5 Day Moving Average | $33.66(-3.89%) | 10 Day Moving Average | $34.23(-5.49%) | 20 Day Moving Average | $36.4(-11.13%) | To recent high | -21.2% | To recent low | 1.7% | Market Cap | $4.421b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |